This is a bonus episode of the audio of a Breastcancer.org ⁠webinar⁠.

Whether you’re adjusting to changes to your body, experiencing weight fluctuation, hair loss, hot flashes, or just trying to feel “like yourself” again, this webinar will give you a toolkit of style strategies to try.

Dr. Weiss and Emma John discuss their personal stories, and how self-expression through style has helped them after breast cancer. They’ll share practical, affordable ideas to help you feel comfortable, confident, and stylish—no matter where you are in your treatment for breast cancer. 

Topics include: 

This episode is for anyone who wants to reclaim your sense of self, or develop a whole new style that feels right for you. Remember, style is not about chasing trends or fitting into someone else’s idea of beauty. It’s about honoring your story, embracing your body as it is today, and finding moments of joy. 

Featured Speakers:

Emma John
Personal Stylist and Founder, Sisterhood of Style

Marisa Weiss, MD
Chief Medical Officer, Breastcancer.org

Antibody-drug conjugates (ADCs) are a relatively new type of medicine for breast cancer. Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) and Dato-DXd (brand name: Datroway) are two ADCs used to treat breast cancer.

Dr Benjamin Schrank and colleagues have developed a new type of ADC that combines an antibody with a toxin — called an antibody-toxin conjugate — that teaches the immune system to recognize and attack cancer cells.

Listen to the episode to hear Dr. Schrank explain:

Episode image photo credit: The University of Texas MD Anderson Cancer Center

At the start of her second trimester, Rafaela Dreisin was diagnosed with breast cancer at the age of 36. Listen to the episode to hear Rafaela discuss:

This is a bonus episode of the audio of a Breastcancer.org webinar.

It’s normal to experience emotional challenges after a cancer diagnosis. From body image to managing relationships, heightened stress, the fear of recurrence, and so much more. 

In this webinar, you’ll learn about a variety of ways to cope with the anxiety and doubts that can take hold. 

Breast cancer patients and survivors will share what helps them manage their mental health struggles. They discuss candidly how they find strength and hope even on their most difficult days.  

We'll also hear from experts on finding mental health support and different approaches to getting the help you need. 

After you watch the webinar, hear Dr. Stephanie Ross answer more audience questions in a “Stage Free” podcast interview. And learn more about taking care of your mental health after a breast cancer diagnosis.

Featured Speakers:

Martha Gamez-Smith
Breast Cancer Advocate

Loriana Hernández-Aldama
Founder, ArmorUp for LIFE

Allison Ko
Metastatic Breast Cancer Advocate

Stephanie Ross, PhD
Founder, Illness Navigation Resources

Carolyn Teschler
Breast Cancer Advocate

Tiah Tomlin-Harris
Breast Cancer Advocate, Breastcancer.org Virtual Support Group facilitator

Marisa Weiss, MD
Chief Medical Officer, Breastcancer.org

This podcast is the audio from a special Virtual Support Group meetup featuring guest moderator Joanna Doran.

Listen to the podcast to hear Joanna and Community members discuss:

This podcast is the audio from a special Virtual Support Group featuring guest moderator Kelly Grosklags.

Listen to the podcast to hear Kelly and Community members discuss:

Four years after giving birth to her son, Jaci Field was diagnosed with breast cancer at age 39.

Listen to the episode to hear Jaci discuss:

her breast cancer experience and her advocacy work

the  discrimination she’s faced, both because of her race and whom she chooses to love

how she finds joy

At the 2025 American Society of Clinical Oncology Annual Meeting, Hope Rugo, MD, chaired a session on managing the side effects of new breast cancer treatments and also presented information on how to manage the side effects of hormonal therapy medicines, which are used to treat hormone receptor-positive breast cancer.

Listen to the episode to hear Dr. Rugo explain:

At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting Fumiko Chino, MD, summarized her presentation on how doctors can help the people they care for overcome financial issues. She also offered some strategies for patients.

Listen to the podcast to hear Dr. Chino explain:

some specific resources for people with cancer

why people with breast cancer may have the most financial issues

her top three recommendations for people having financial hardship

The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting featured five days of presentations and educational sessions on all types of cancer. Dr. Eleonora Teplinsky, a board-certified medical oncologist at the Valley-Mount Sinai Comprehensive Cancer Center in Paramus, NJ, summarizes the top breast cancer research.

Listen to the episode to hear Dr. Teplinsky discuss:

The SERENA-6 trial, which found that if metastatic hormone receptor-positive, HER2-negative breast cancer develops ESR1 mutations during first hormonal therapy treatment, switching to camizestrant from an aromatase inhibitor before the cancer grows improves outcomes.

Results from the DESTINY-Breast09 trial showing that the combination of Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) and Perjeta (chemical name: pertuzumab) is a better first treatment for metastatic HER2-positive breast cancer than the current standard of THP chemo. 

The ASCENT-04/KEYNOTE-D19 trial, which found that people with metastatic, PD-L1-positive, triple-negative breast cancer fared better with the combo of Trodelvy (chemical name: sacituzumab govitecan-hziy) and Keytruda (chemical name: pembrolizumab) as a first treatment compared to people who received chemotherapy and Keytruda.